Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

EnteroMedics retools, refocuses to win FDA approval
Med City News
Saturday, March 13, 2010 - 10:55am
tags:
EnteroMedics, obesity, Maestro
Ranbaxy eyes 80% rise in income by end of 2012
Sify, India
Saturday, March 13, 2010 - 10:52am
tags:
Ranbaxy, Daiichi Sankyo
Merck's New Cholesterol Pill Gets A Boost
Investor's Business Daily
Saturday, March 13, 2010 - 10:38am
tags:
Merck, Vytorin
Pfizer's 3 Points of Failure
Motley Fool
Saturday, March 13, 2010 - 10:34am
tags:
Pfizer, Sutent, dimebon, figitumumab
Analyst: Merck's Vytorin sales will keep dropping
Yahoo/AP
Saturday, March 13, 2010 - 10:33am
tags:
Merck, Vytorin
Sanofi-aventis and Bristol-Myers Squibb Announce Important Updates to PLAVIX U.S. Prescribing Information
Yahoo/BusinessWire
Saturday, March 13, 2010 - 10:30am
tags:
Sanofi, Bristol-Myers Squibb, Plavix
Cancer Drugs May Not Cure Pfizer
Forbes
Saturday, March 13, 2010 - 10:28am
tags:
Pfizer, Sutent, figitumumab, Avastin
Halozyme narrows 4Q loss due to Hylenex payment
Yahoo/AP
Saturday, March 13, 2010 - 10:25am
tags:
Halozyme, Hylenex, Roche
Federman & Sherwood Announces That a Securities Class Action Lawsuit Has Been Filed Against Cell Therapeutics, Inc.
Yahoo/MarketWire
Saturday, March 13, 2010 - 10:24am
tags:
Cell Therapeutics, lawsuits
Genzyme discloses contamination at Ireland plant
bizjournals.com
Saturday, March 13, 2010 - 10:22am
tags:
Genzyme, Cerezyme
Brower Piven Encourages Investors Who Have Losses in Excess of $50,000 From Investment in Novelos Therapeutics, Inc. to Inquire About the Lead Plaintiff Position
MarketWire
Saturday, March 13, 2010 - 10:21am
tags:
Novelos Therapeutics, lawsuits
GenVec shares rise on narrower 4th-quarter loss
Yahoo/AP
Saturday, March 13, 2010 - 10:14am
tags:
GenVec, TNFerade
Abbott shares dip, analyst sees profit concerns
Yahoo/AP
Saturday, March 13, 2010 - 10:11am
tags:
Abbott Laboratories
Optimer Pharma reports narrower 4th-quarter loss
Yahoo/AP
Saturday, March 13, 2010 - 10:09am
tags:
Optimer
Obagi 4Q profit doubles on skin product sales
Yahoo/AP
Saturday, March 13, 2010 - 10:06am
tags:
Obagi Medical Products, Nu-Derm
Oncothyreon to restate financial statements
bizjournals.com
Saturday, March 13, 2010 - 10:05am
tags:
Pfizer Fails… Again
Minyanville
Saturday, March 13, 2010 - 10:02am
tags:
Sutent, non-small cell lung cancer, Pfizer, figitumumab, breast cancer
Ligand Announces Approval for Revolade in Europe
Yahoo/BusinessWire
Saturday, March 13, 2010 - 10:00am
tags:
Ligand, Revolade, thrombocytopenia
Daiichi aims to double profits by 2013
Fierce Pharma
Friday, March 12, 2010 - 11:24am
tags:
Daiichi Sankyo, guidance
Abbott, Pfizer lead drug stocks lower
Marketwatch
Friday, March 12, 2010 - 11:10am
tags:
Abbott Laboratories, Pfizer, drug stocks

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.